And last month, cancer society researchers reported that colorectal cancer mortality in Americans under 50 had increased by 1.1% a year since 2005, becoming the deadliest cancer in that age group.

The U.S. FDA has granted orphan drug designation to HCB101, an investigational immunotherapy, for the treatment of gastric cancer.

Even before a tumor in the pancreas becomes discernible, an activated cancer gene actively remodels its future environment and creates an inflammatory and immune-defensive microenvironment in which ...

A Clayman Thyroid Center report aims to clarify FDA safety warnings, finding no evidence that GLP-1 drugs like Ozempic cause common thyroid cancers. Current human data do not show a link between GLP-1 ...

International variation in population-level overall survival in some childhood cancers is associated with differences ...

Winning approval to target the 15,000 U.S. patients with locally advanced pancreatic cancer is the first step in a broader expansion in the tumor type.

Cancer is increasingly recognized as a dynamic and adaptive network disease characterized by pathway redundancy, tumor ...

The visual nature of head and neck cancer calls for treatment strategies that will minimize toxicities related to radiation therapy. Advances in precision radiation techniques, supportive care, and ...

No one is promised tomorrow. Why waste the days I’ve been given stressing about death?” Katie Thurston tells PEOPLE ...

The FDA has approved a first-of-its-kind wearable electrical device — Optune Pax (Novocure) — for patients with locally ...

The FDA has approved a first-of-its-kind portable, noninvasive device that delivers alternating electrical fields for the treatment of locally advanced pancreatic cancer.Optune Pax (Novocure) releases ...

Neoadjuvant immunotherapy could considerably improve long-term outcomes and quality of life for patients with desmoplastic melanoma, according to prospective study results.Nearly three-quarters of ...